Q1 2025 · 13F-HR
Catalio Capital Management, LPholdings as filed
Filed 2025-05-15 · accession 0001958125-25-000004
$411.1M
Reported value
37
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 075887109 | BDX | BECTON DICKINSON & CO | $46.7M | 11.4% | 203,965 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $33.5M | 8.14% | 758,533 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $33.3M | 8.10% | 962,883 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $31.6M | 7.68% | 435,588 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $30.5M | 7.41% | 195,523 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $23.5M | 5.73% | 585,812 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $22.6M | 5.50% | 762,225 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $21.3M | 5.18% | 1,733,701 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $19.6M | 4.76% | 23,682 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $18.1M | 4.40% | 36,499 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $15.0M | 3.65% | 381,648 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $13.8M | 3.37% | 763,471 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $13.7M | 3.33% | 85,877 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $12.2M | 2.97% | 704,864 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $11.5M | 2.80% | 160,962 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $8.8M | 2.14% | 830,325 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $7.8M | 1.89% | 12,261 | Common | SOLE |
| 834203909 | — | SOLENO THERAPEUTICS INC | $6.5M | 1.58% | 100,000 | CALL | NONE |
| 81734D104 | SEPN | SEPTERNA INC | $5.9M | 1.44% | 1,024,245 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $4.6M | 1.13% | 1,088,691 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4.5M | 1.11% | 611,639 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $4.5M | 1.09% | 114,616 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $4.0M | 0.97% | 389,384 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $4.0M | 0.96% | 611,608 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.5M | 0.84% | 355,640 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $2.3M | 0.57% | 295,148 | Common | SOLE |
| 690145206 | OM | OUTSET MED INC | $1.8M | 0.45% | 166,666 | Common | SOLE |
| 03969K958 | — | ARCUTIS BIOTHERAPEUTICS INC | $1.3M | 0.30% | 100,000 | PUT | NONE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $1.1M | 0.28% | 586,909 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $719,430 | 0.17% | 528,993 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $586,873 | 0.14% | 1,705,036 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $582,160 | 0.14% | 202,139 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $582,026 | 0.14% | 155,622 | Common | SOLE |
| 44916K106 | HYPR | HYPERFINE INC | $544,413 | 0.13% | 760,035 | Common | SOLE |
| N0731H103 | ATAI | ATAI LIFE SCIENCES NV | $267,727 | 0.07% | 196,858 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $254,941 | 0.06% | 214,236 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $115,983 | 0.03% | 294,374 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.